79 results
Page 4 of 4
8-K
EX-99.1
fzvp usowkrxh
20 Oct 16
Regulation FD Disclosure
12:00am
8-K
EX-99.1
xakm 0u60uz
8 Apr 14
Alkermes Announces Positive Topline Results from Pivotal Phase 3 Study of Aripiprazole Lauroxil for Treatment of Schizophrenia
12:00am
10-KT
xbtway18a z84wppu
27 Feb 14
Annual report (with FYE transition)
12:00am
8-K
EX-10.1
vmc 85oitg
25 Sep 12
Alkermes PLC Closes Debt Refinancing, Lowering Interest Rate and Reducing Principal Amount
12:00am
10-K
sxscgln0gv
18 May 12
Annual report
12:00am
424B3
svnygvh7
8 Mar 12
Prospectus supplement
12:00am
424B3
jcj8 neylf
8 Mar 12
Prospectus supplement
12:00am
8-K
EX-10.2
1ymd5vebhn6gzq6m
5 Mar 12
Departure of Directors or Certain Officers
12:00am
DEF 14A
jvrjvr7cq3a20wr44l
4 Nov 11
Definitive proxy
12:00am
8-K
EX-10.7
fht1osy3jelg0xcjq1
20 Sep 11
Departure of Directors or Certain Officers
12:00am
424B3
ui3ryo0n klvcdgyhby7
5 Aug 11
Prospectus supplement
12:00am
S-4/A
bjq brixp7f
2 Aug 11
Registration of securities issued in business combination transactions (amended)
12:00am
S-4
bvs4 psvn5
23 Jun 11
Registration of securities issued in business combination transactions
12:00am